APA (7th ed.) Citation

Hummelink, K., van der Noort, V., Muller, M., Schouten, R. D., van den Heuvel, M. M., Thommen, D. S., . . . Monkhorst, K. (2024). Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. PLoS ONE, 19(7), 1. https://doi.org/10.1371/journal.pone.0293707

Chicago Style (17th ed.) Citation

Hummelink, Karlijn, Vincent van der Noort, Mirte Muller, Robert D. Schouten, Michel M. van den Heuvel, Daniela S. Thommen, Egbert F. Smit, Gerrit A. Meijer, and Kim Monkhorst. "Head-to-head Comparison of Composite and Individual Biomarkers to Predict Clinical Benefit to PD-1 Blockade in Non-small Cell Lung Cancer." PLoS ONE 19, no. 7 (2024): 1. https://doi.org/10.1371/journal.pone.0293707.

MLA (9th ed.) Citation

Hummelink, Karlijn, et al. "Head-to-head Comparison of Composite and Individual Biomarkers to Predict Clinical Benefit to PD-1 Blockade in Non-small Cell Lung Cancer." PLoS ONE, vol. 19, no. 7, 2024, p. 1, https://doi.org/10.1371/journal.pone.0293707.